Survey: Prescription drug trends to increase by double-digits
NEW YORK — Health benefit plan cost trend rates for 2016 will increase for most medical plan options and increase substantially for prescription drug coverage to double-digit rates, according to forecasts compiled in the 2016 Segal Health Plan Cost Trend Survey, Segal’s nineteenth annual survey of health plan cost trends. Trend is the forecast of annual gross per capita claims cost increases.
“Whether it is new high-tech surgical or diagnostic procedures replacing lower-cost options, or extremely high-cost specialty biotech drugs growing in popularity, plan sponsors still face significant challenges to manage medical plan cost trends to more sustainable long-term levels,” said Edward Kaplan, National Health Practice Leader at The Segal Group. “Plan sponsors have already put cost-management strategies, such as adding narrower provider networks and using specialty pharmacy management, into place.”
Other prescription drug coverage findings included:
- Trend rates for prescription drug coverage are expected to be significantly higher in 2016: 11.3% for carve-out coverage for actives and retirees under age 65 years and 10.9% for retirees ages 65 years and over. Both projections are roughly 3 percentage points greater than projections for 2015.
- The projected specialty drug/biotech drug cost trend rate is expected to remain high at 18.9%, but slightly lower than the projection for 2015.
- Price inflation for prescription drugs and hospital stays are the overwhelming driver of cost increases, especially for prescription drugs, where trend is approaching double digits (9.8%).
The Segal survey included data from managed care organizations, health insurers, pharmacy benefit managers and third-party administrators. For complete survey results, click here.
30-year retail-pharmacy leader joins CARE board
FlavoRx, RxNT streamline process of flavoring pediatric meds
COLUMBIA, Md. — Software solutions company RxNT and FlavoRx announced Thursday a streamlined way for prescribers and patients to get flavored pediatric medications, potentially boosting adherence. Now prescribers who e-prescribe medication or keep records through RxNT’s eRx or EHR can designate a patient’s preferred medication flavor and communicate it to pharmacists.
“Allowing patients to choose the taste of their medication can play an important role in pediatric adherence,” FlavoRx CEO Stuart Amos said. “For prescribers that use RxNT’s e-prescribing solution (RxNT|eRx) or its full electronic health record solution (RxNT|EHR), they simply need to click the FLAVORx option on the screen to recommend customizing the taste of medications, which now can be covered by the patients FSA or HSA.”
The move comes as eprescribing is on the rise, with 56% of physicians reporting that the prescribe medications electronically, according to Surescripts’ 2014 National Progress Report. The taste selector and pediatric dosage calculator are core components of RxNT’s solutions.
“The benefits of ePrescribing are significant for the entire healthcare community, and it is clear ePrescribing is here to stay,” Tom Collinson, EVP Business Development at RxNT, said. “With that in mind, we continue to make enhancements to our solutions that further simplify and streamline the workflow of physicians and their practices.”